Show simple item record

dc.contributor.advisorUddin, Md. Jasim
dc.contributor.authorChowdhury, Tasnia Farheen
dc.date.accessioned2021-10-21T05:36:17Z
dc.date.available2021-10-21T05:36:17Z
dc.date.copyright2021
dc.date.issued2021-08
dc.identifier.otherID 17346011
dc.identifier.urihttp://hdl.handle.net/10361/15508
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 42-52).
dc.description.abstractCOVID-19 has an impact on people of all ages, races, and ethnicities. Because many infected persons are asymptomatic, the virus is unknowingly transmitted to others, resulting in a rapid spread of illness. Spike protein (S) of coronavirus is a distinctive secondary element of the viral envelope which is regarded as a major target of antibodies designed to detect coronavirus contamination. Microneedle methods, particularly dissolving microneedles, are very helpful and beneficial for achieving herd immunity in the population. There will be increased immunogenicity, less vaccination waste, customized distribution, and so forth. Hollow microneedles and solid microneedles are also viable options for producing the vaccine of COVID-19, and the materials used to make them include ceramic, polymers, carbohydrates, hydrogels, and so on. In order to protect people in this worldwide epidemic, this may be an excellent way of vaccinating against this lethal virus while also ensuring patient compliance.en_US
dc.description.statementofresponsibilityTasnia Farheen Chowdhury
dc.format.extent52 pages
dc.language.isoenen_US
dc.publisherBrac Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectCovid-19en_US
dc.subjectVaccinationen_US
dc.subjectTransdermalen_US
dc.subjectMicroneedlesen_US
dc.subject.lcshCOVID-19 (Disease)
dc.subject.lcshVaccines
dc.subject.lcshTransdermal medication
dc.titleTransdermal material construction in covid 19 vaccine delivery: a microneedle approachen_US
dc.typeThesisen_US
dc.contributor.departmentDepartment of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record